These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 34921949)
1. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP/m Wei A; Zhao F; Hao A; Liu B; Liu Z Gene; 2022 Mar; 813():146125. PubMed ID: 34921949 [TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats. Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324 [TBL] [Abstract][Full Text] [Related]
3. Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver. Chen YW; Liu BW; Zhang YJ; Chen YW; Dong GF; Ding XD; Xu LM; Pat B; Fan JG; Li DG J Hepatol; 2010 Sep; 53(3):528-36. PubMed ID: 20646773 [TBL] [Abstract][Full Text] [Related]
4. [Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline mediated by regulation of transforming growth factor beta and connective tissue growth factor expression on rats with silicosis]. Li Q; Yang F; Zhang LJ; Yan JB; Chen P; Li DD; Wu KF Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 Jul; 27(7):390-4. PubMed ID: 20039536 [TBL] [Abstract][Full Text] [Related]
5. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on regulation of expression of ras-raf-ERK1/2 signal transduction pathway in lung of rats with silicosis]. Tian JR; Yang F; Li DD; Zhang LJ; Wei ZQ; Feng HL; Li ZG; Wang RM Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Oct; 28(10):760-5. PubMed ID: 21126429 [TBL] [Abstract][Full Text] [Related]
6. ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m Yang JJ; Wang J; Yang Y; Yang Y; Li J; Lu D; Lu C Eur J Pharmacol; 2022 May; 922():174900. PubMed ID: 35318034 [TBL] [Abstract][Full Text] [Related]
7. [Regulating effect of N-acetyl-seryl-aspartyl-lysyl-proline on activation of c-jun N-terminal kinase pathway in rats with silicosis]. Wei ZQ; Yu WY; Feng HL; Ma WD; Li ZG; Xu H; Wang RM; Yang F Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 May; 31(5):335-40. PubMed ID: 23803521 [TBL] [Abstract][Full Text] [Related]
8. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis. Feng J; Wang C; Liu T; Li J; Wu L; Yu Q; Li S; Zhou Y; Zhang J; Chen J; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C J Cell Mol Med; 2019 Sep; 23(9):6479-6493. PubMed ID: 31328391 [TBL] [Abstract][Full Text] [Related]
9. Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992 [TBL] [Abstract][Full Text] [Related]
10. [Anti-fibrotic role of AcSDKP through inhibition of P38MAPK pathway activity mediated transforming growth beta receptors in rat with silicosis]. Wei Z; Sun Y; Cheng H; Ma W; Xu H; Li Q; Zhang L; Wang R; Yang F Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 May; 32(5):340-7. PubMed ID: 25169087 [TBL] [Abstract][Full Text] [Related]
11. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
12. Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline. Zhang Y; Zhang ZG; Chopp M; Meng Y; Zhang L; Mahmood A; Xiong Y J Neurosurg; 2017 Mar; 126(3):782-795. PubMed ID: 28245754 [TBL] [Abstract][Full Text] [Related]
13. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis. Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816 [TBL] [Abstract][Full Text] [Related]
14. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis. Zhang X; Zhou J; Zhu Y; He L; Pang Z; Wang Z; Xu C; Zhang C; Hao Q; Li W; Zhang W; Zhang Y; Li M IUBMB Life; 2019 Sep; 71(9):1302-1312. PubMed ID: 30900390 [TBL] [Abstract][Full Text] [Related]
15. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935 [TBL] [Abstract][Full Text] [Related]
16. Cryptolepine derivative-6h inhibits liver fibrosis in TGF-β1-induced HSC-T6 cells by targeting the Shh pathway. He YH; Li Z; Ni MM; Zhang XY; Li MF; Meng XM; Huang C; Li J Can J Physiol Pharmacol; 2016 Sep; 94(9):987-95. PubMed ID: 27295431 [TBL] [Abstract][Full Text] [Related]
17. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke. Zhang L; Chopp M; Teng H; Ding G; Jiang Q; Yang XP; Rhaleb NE; Zhang ZG Stroke; 2014 Apr; 45(4):1108-14. PubMed ID: 24549864 [TBL] [Abstract][Full Text] [Related]
18. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431 [TBL] [Abstract][Full Text] [Related]
19. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway. Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501 [TBL] [Abstract][Full Text] [Related]